Literature DB >> 20306112

Estimates of patient costs related with population morbidity: can indirect costs affect the results?

M Carreras1, M García-Goñi, P Ibern, J Coderch, L Vall-Llosera, J M Inoriza.   

Abstract

A number of health economics studies require patient cost estimates as basic information input. However, the accuracy of cost estimates remains generally unspecified. We propose to investigate how the allocation of indirect costs or overheads can affect the estimation of patient costs and lead to improvements in the analysis of patient cost estimates. Instead of focussing on the costing method, this paper will highlight observed changes in variation explained by a methodology choice. We compare four overhead allocation methods for a specific Spanish population adjusted using the Clinical Risk Groups model. Our main conclusion is that the amount of global variation explained by the risk adjustment model depends mainly on direct costs, regardless of the cost allocation methodology used. Furthermore, the variation explained can be slightly increased, depending on the cost allocation methodology, and is independent of the level of aggregation in the classification system.

Entities:  

Mesh:

Year:  2010        PMID: 20306112     DOI: 10.1007/s10198-010-0227-5

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  11 in total

1.  Clinical Risk Groups (CRGs): a classification system for risk-adjusted capitation-based payment and health care management.

Authors:  John S Hughes; Richard F Averill; Jon Eisenhandler; Norbert I Goldfield; John Muldoon; John M Neff; James C Gay
Journal:  Med Care       Date:  2004-01       Impact factor: 2.983

2.  The analysis of incomplete cost data due to dropout.

Authors:  Jan B Oostenbrink; Maiwenn J Al
Journal:  Health Econ       Date:  2005-08       Impact factor: 3.046

3.  Collecting unit cost data in multicentre studies. Creating comparable methods.

Authors:  Sarah Wordsworth; Anne Ludbrook; Fergus Caskey; Alison Macleod
Journal:  Eur J Health Econ       Date:  2005-03

4.  Predictability of drug expenditures: an application using morbidity data.

Authors:  Manuel García-Goñi; Pere Ibern
Journal:  Health Econ       Date:  2008-01       Impact factor: 3.046

5.  The impact of using different costing methods on the results of an economic evaluation of cardiac care: microcosting vs gross-costing approaches.

Authors:  Fiona M Clement Nee Shrive; William A Ghali; Cam Donaldson; Braden J Manns
Journal:  Health Econ       Date:  2009-04       Impact factor: 3.046

Review 6.  Cost data for individual patients included in clinical studies: no amount of statistical analysis can compensate for inadequate costing methods.

Authors:  Nicholas Graves; Damian Walker; Rosalind Raine; Andrew Hutchings; Jennifer A Roberts
Journal:  Health Econ       Date:  2002-12       Impact factor: 3.046

7.  [Measurement of morbidity attended in an integrated health care organization].

Authors:  José M Inoriza; Jordi Coderch; Marc Carreras; Laura Vall-Llosera; Manuel García-Goñi; Josep M Lisbona; Pere Ibern
Journal:  Gac Sanit       Date:  2009-01-09       Impact factor: 2.139

8.  VA community-based outpatient clinics: cost performance measures.

Authors:  Matthew L Maciejewski; Michael K Chapko; Ashley N Hedeen; John C Fortney
Journal:  Med Care       Date:  2002-07       Impact factor: 2.983

9.  Missing... presumed at random: cost-analysis of incomplete data.

Authors:  Andrew Briggs; Taane Clark; Jane Wolstenholme; Philip Clarke
Journal:  Health Econ       Date:  2003-05       Impact factor: 3.046

10.  Profile of medical charges for children by health status group and severity level in a Washington State Health Plan.

Authors:  John M Neff; Virginia L Sharp; John Muldoon; Jeff Graham; Kristin Myers
Journal:  Health Serv Res       Date:  2004-02       Impact factor: 3.402

View more
  7 in total

1.  Estimating lifetime healthcare costs with morbidity data.

Authors:  Marc Carreras; Pere Ibern; Jordi Coderch; Inma Sánchez; Jose M Inoriza
Journal:  BMC Health Serv Res       Date:  2013-10-25       Impact factor: 2.655

2.  Analysing the Costs of Integrated Care: A Case on Model Selection for Chronic Care Purposes.

Authors:  Marc Carreras; Inma Sánchez-Pérez; Pere Ibern; Jordi Coderch; José María Inoriza
Journal:  Int J Integr Care       Date:  2016-08-19       Impact factor: 5.120

3.  Standardised mortality rate for cerebrovascular diseases in the Slovak Republic from 1996 to 2013 in the context of income inequalities and its international comparison.

Authors:  Beáta Gavurová; Viliam Kováč; Tatiana Vagašová
Journal:  Health Econ Rev       Date:  2017-02-02

4.  [Morbidity observed in a health area: Impact on professionals and funding].

Authors:  Pablo de Miguel; Isabel Caballero; Francisco Javier Rivas; Jaime Manera; María Auxiliadora de Vicente; Ángel Gómez
Journal:  Aten Primaria       Date:  2014-10-23       Impact factor: 1.137

5.  Regional differences of standardised mortality rates for ischemic heart diseases in the Slovak Republic for the period 1996-2013 in the context of income inequality.

Authors:  Beáta Gavurová; Tatiana Vagašová
Journal:  Health Econ Rev       Date:  2016-06-04

6.  Hospital Costs of Foreign Non-Resident Patients: A Comparative Analysis in Catalonia, Spain.

Authors:  Elena Arroyo-Borrell; Gemma Renart-Vicens; Marc Saez; Marc Carreras
Journal:  Int J Environ Res Public Health       Date:  2017-09-14       Impact factor: 3.390

7.  [Impact of cardiovascular risk factors on the consumption of resources in Primary Care according to Clinical Risk Groups].

Authors:  Magdalena Millá Perseguer; Natividad Guadalajara Olmeda; David Vivas Consuelo
Journal:  Aten Primaria       Date:  2018-06-13       Impact factor: 1.137

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.